Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial

By sjmartinez • March 7, 2023

Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, Ding X, Hao X, Yang H, Sha W. Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial. Emerg Microbes Infect. 2023 Mar 6:2187247. doi: 10.1080/22221751.2023.2187247. Epub ahead of print. PMID: 36872899.

Tags: clofazimine, Infectious Diseases, Parabolic Response Surface, Publications, pulmonary tuberculosis, Randomized clinical trial, Short-course treatment

Related Posts

Clinical utility of serial plasma cell-free DNA metagenomic next-generation sequencing assays

Kaur I, Shaw B, Multani A, Malhotra S, Dong HV, Lukose C, Prabaker K, Saleh T, Sim YB, Tymchuk CN, Uslan DZ, Zhou H, Brewer[...]

Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV

Arant EC, Davy-Mendez T, Liang T, Rodrigues M, Gay CL, Rana MM, Friedman-Moraco R, Gilbert A, Stock P, Mehta SA, Mehta S, Stosor V, Pereira[...]

Exploration of Pregnant and Breastfeeding Women’s Acceptability of Rapid Point-of-Care Urine Testing Within Antenatal and Postnatal Care, and Its Perceived Impact on PrEP Adherence When Paired with PrEP Biofeedback Adherence Counselling in Cape Town, South Africa

Court L, Mvududu R, Schoetz Dean S, Knight L, Dovel K, Gandhi M, Myer L, Coates T, Joseph Davey DL. Exploration of Pregnant and Breastfeeding[...]